Skip to main content

Ligand Pharmaceuticals Inc

LGND
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000886163

In the last 90 days, Ligand Pharmaceuticals Inc insiders filed 0 open-market purchases and 6 sales; 416 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.

Other share classesLGNDZLGNXZLGNYZLGNZZ

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ligand Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $16.1M in total
Insiders trading
4
Net value
−$16.1M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ligand Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ligand Pharmaceuticals Inc
NameTitleLast reported holdingLast filingFilings, past year
Zimmermann MartineDirector3,782Sep 24, 20263
Reardon AndrewCLO & Secretary36,514Sep 8, 20269
Espinoza OctavioChief Financial Officer27,696Aug 14, 202611
Haas JasonDirector3,981Aug 14, 20263
Davis Todd CChief Executive Officer199,513Jul 6, 20264
Sabba Stephen LDirector33,629Jun 18, 20264
Lamattina John LDirector26,969Jun 12, 20264
Aryeh JasonDirector102,580Jun 12, 20262
Kozarich John WDirector42,622Jun 9, 20269
Gray Nancy RyanDirector8,930Jun 9, 20262
Korenberg Matthew EPresident & COO50,777Sep 24, 20240
Higgins John LDirector417,695Dec 30, 20220
Foehr Matthew WOther: Former Executive Officer162,187Nov 3, 20220
Berkman Charles SOther: Former Executive Officer23,825Nov 3, 20220
Patel SunilOther: Former Director28,820Nov 3, 20220
Boyce SarahOther: Former Director2,892Nov 3, 20220
Cochran Jennifer R.Other: Former Director1,161Nov 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2021 (view filing)Aug 41 dayFoehr Matthew WPresident and COOSSale−8.84K$109.67−$969.5K−5.1%164.4K after
Nov 12, 2021 (view filing)Nov 111 dayFoehr Matthew WPresident and COOSSale−11.2K$163.02−$1.82M−6.3%166.5K after
Nov 12, 2021 (view filing)Nov 12Same dayHiggins John LChief Executive OfficerSSale−3.00K$160.50−$481.5K−0.9%335.1K after
Nov 17, 2021 (view filing)Nov 161 dayLamattina John LDirectorSSale−4.83K$161.86−$782.6K−16.0%25.4K after
Mar 1, 2022 (view filing)Feb 281 dayKozarich John WDirectorSSale−908$102.62−$93.2K−2.2%41.2K after
May 10, 2022 (view filing)5:33 PM ETMay 10Same dayHiggins John LChief Executive OfficerSSale0.75% Convertible Senior Notes due 2023––––DerivativePrice outlier
May 13, 2022 (view filing)May 13Same dayFoehr Matthew WPresident and COOPPurchase+2.50K$82.76+$206.9K+1.5%173.4K after
Sep 16, 2022 (view filing)Sep 151 dayHiggins John LChief Executive OfficerSSale−2.00K$90.00−$180.0K−0.5%367.2K afterFrom original
Sep 22, 2022 (view filing)Sep 166 daysHiggins John LChief Executive OfficerSSale−1.00K$88.06−$88.1K−0.3%366.2K afterAmended
Nov 10, 2022 (view filing)Nov 91 dayEspinoza OctavioChief Financial OfficerSSale−1.70K$75.64−$128.3K−16.1%8.86K after
Nov 21, 2022 (view filing)Nov 174 daysHiggins John LChief Executive OfficerSSale−10.0K$78.32−$783.2K−2.3%416.7K after
Dec 20, 2022 (view filing)Dec 164 daysHiggins John LDirectorSSale−10.0K$61.87−$618.7K−2.3%423.0K after
Mar 28, 2023 (view filing)Mar 244 daysReardon AndrewSee RemarksSSale−300$69.92−$21.0K−1.8%16.3K after
May 10, 2023 (view filing)May 82 daysKozarich John WDirectorSSale−6.41K$76.56−$490.6K−13.2%42.2K after2 lots
May 12, 2023 (view filing)May 102 daysSabba Stephen LDirectorSSale−6.41K$77.13−$494.2K−19.9%25.8K after
May 18, 2023 (view filing)May 162 daysKozarich John WDirectorSSale−4.44K$77.20−$343.1K−10.4%38.5K after
Sep 25, 2023 (view filing)Sep 223 daysDavis Todd CCHIEF EXECUTIVE OFFICERPPurchase+4.00K$59.38+$237.5K+5.8%73.1K after
Feb 29, 2024 (view filing)Feb 281 dayEspinoza OctavioChief Financial OfficerSSale−140$88.46−$12.4K−0.5%29.8K after
Mar 7, 2024 (view filing)Mar 52 daysSabba Stephen LDirectorSSale−1.89K$74.30−$140.6K−6.1%28.9K after
May 13, 2024 (view filing)May 94 daysReardon AndrewChief Legal Officer &SSale−10.0K$83.04−$830.4K−31.1%22.2K after
May 15, 2024 (view filing)May 13-142 daysKorenberg Matthew EPresident & Chief OperatingSSale−17.6K$84.99−$1.50M−16.9%86.3K after3 lots
May 17, 2024 (view filing)May 15-172 daysEspinoza OctavioChief Financial OfficerSSale−13.3K$86.26−$1.15M−36.2%23.4K after4 lots
May 17, 2024 (view filing)May 98 daysLateGray Nancy RyanDirectorSSale−934$83.20−$77.7K−14.2%5.63K after
Aug 9, 2024 (view filing)Aug 81 dayDavis Todd CChief Executive OfficerPPurchase+2.50K$97.39+$243.5K+2.1%123.0K after
Aug 13, 2024 (view filing)Aug 94 daysKorenberg Matthew EPresident & COOSSale−18.2K$98.50−$1.80M−21.1%68.4K after
Aug 26, 2024 (view filing)Aug 22-264 daysKorenberg Matthew EPresident & COOSSale−18.9K$105.34−$1.99M−27.6%49.5K after5 lots
Aug 30, 2024 (view filing)Aug 282 daysReardon AndrewCLO & SecretarySSale−1.50K$106.39−$159.6K−6.2%22.5K after
Sep 24, 2024 (view filing)Sep 20-234 daysKorenberg Matthew EPresident & COOSSale−16.0K$102.35−$1.64M−24.0%50.8K after4 lots
Sep 24, 2024 (view filing)Sep 204 daysEspinoza OctavioChief Financial OfficerSSale−1.27K$103.94−$132.5K−4.9%24.6K after3 lots
Sep 25, 2024 (view filing)Sep 232 daysReardon AndrewCLO & SecretarySSale−2.00K$99.60−$199.2K−8.2%22.5K after
Dec 2, 2024 (view filing)Nov 275 daysLamattina John LDirectorSSale−2.41K$123.65−$297.5K−7.5%29.5K after
Dec 26, 2024 (view filing)Dec 233 daysEspinoza OctavioChief Financial OfficerSSale−2.10K$116.37−$244.8K−9.2%20.6K after
Mar 6, 2025 (view filing)Mar 42 daysEspinoza OctavioChief Financial OfficerSSale−5.00K$115.03−$575.1K−20.9%18.9K after
May 13, 2025 (view filing)May 94 daysEspinoza OctavioChief Financial OfficerPPurchase+1.50K$104.06+$156.1K+5.7%27.9K after2 lots
May 13, 2025 (view filing)May 94 daysDavis Todd CChief Executive OfficerPPurchase+9.51K$105.20+$1.00M+6.3%161.2K after3 lots
Jun 2, 2025 (view filing)May 1518 daysLateReardon AndrewCLO & SecretarySSale−1.00K$104.00−$104.0K−2.9%32.9K after
Jun 12, 2025 (view filing)Jun 102 daysReardon AndrewCLO & SecretarySSale−500$114.54−$57.3K−1.5%32.4K after
Jun 24, 2025 (view filing)Jun 231 dayReardon AndrewCLO & SecretarySSale−500$114.08−$57.0K−1.5%31.9K after
Jul 11, 2025 (view filing)Jul 101 dayKozarich John WDirectorSSale−934$125.00−$116.8K−2.0%46.5K after10b5-1
Aug 5, 2025 (view filing)Aug 14 daysKozarich John WDirectorSSale−467$131.88−$61.6K−1.0%46.0K after10b5-1
Sep 4, 2025 (view filing)Sep 22 daysKozarich John WDirectorSSale−467$162.26−$75.8K−1.0%45.5K after3 lots10b5-1
Sep 24, 2025 (view filing)Sep 231 dayAryeh JasonDirectorSSale−10.0K$170.81−$1.71M−12.6%69.3K after3 lots
Oct 3, 2025 (view filing)Oct 12 daysKozarich John WDirectorSSale−467$179.45−$83.8K−1.0%45.1K after4 lots10b5-1
Nov 5, 2025 (view filing)Nov 32 daysKozarich John WDirectorSSale−467$191.05−$89.2K−1.0%44.6K after4 lots10b5-1
Nov 12, 2025 (view filing)Nov 75 daysLamattina John LDirectorSSale−4.18K$205.45−$858.6K−12.0%30.7K after2 lots
Nov 12, 2025 (view filing)Nov 75 daysGray Nancy RyanDirectorSSale−6.57K$205.45−$1.35M−44.8%8.09K after2 lots
Dec 3, 2025 (view filing)Dec 12 daysKozarich John WDirectorSSale−467$195.84−$91.5K−1.0%44.1K after7 lots10b5-1
Dec 16, 2025 (view filing)Dec 124 daysEspinoza OctavioChief Financial OfficerSSale−1.80K$188.31−$339.7K−6.4%26.2K after
Jan 6, 2026 (view filing)Jan 24 daysKozarich John WDirectorSSale−467$189.58−$88.5K−1.1%43.7K after5 lots10b5-1
Feb 4, 2026 (view filing)Feb 22 daysKozarich John WDirectorSSale−467$195.91−$91.5K−1.1%43.2K after5 lots10b5-1